Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Close Brothers shares tank as motor finance provisions lead to H1 loss

(Sharecast News) - Close Brothers shares tanked on Tuesday after the merchant banking group swung to a hefty loss in the first half on the back of a £165m provision for motor finance commissions. Looking forward, the company also said that the reinstatement of dividends would be reviewed "once there is further clarity on the financial impact of the FCA review of motor finance commission arrangements and the Supreme Court appeals".

Close Brothers reported a loss before tax of £103m for the six months to 31 January, compared with a £88.1m profit recorded a year earlier.

Despite the £165m motor finance provision already being reported last month, shares were down more than 13% at 299.38p in early deals.

Other key financial metrics weakened over the period, with operating income down 1% at £390m, as a small decline in banking and lower interest income offsetting higher income from the Winterflood brokerage division. The loan book shrank 3% over six months to £9.8bn and net asset value per share fell 8% to £10.10.

Meanwhile, the company's CET1 capital ratio declined to 12.2% from 12.8%. However, after including profits from the disposal of Close Brothers Asset Management, the CET1 capital ratio would have been 13.4%.

"Our goal is to ensure that, once the motor finance commissions uncertainty has been resolved, the group is well positioned to generate strong, sustainable returns," said chief executive Mike Morgan.

"Alongside a stronger capital position, delivering on these priorities will create a more efficient and resilient business, one that delivers greater value for shareholders and continues to support customers, as we have through many cycles."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.